Tag: , , , , ,

Making Ranbaxy units cGMP compliant time consuming: Sun Pharma

New Delhi: Sun Pharma sees remediation process at erstwhile Ranbaxy facilities as a “time consuming” process even as it aims to bring at least one of the plants to conform to current good manufacturing practice regulations (cGMP) in the current fiscal. In the company’s Annual Report for 2015-16, Sun Pharma Managing Director Dilip Shanghvi also

Sun Pharma appoints Abhay Gandhi CEO of North American biz

New Delhi: Drug major Sun Pharma todayannounced a leadership recast in its Indian and North American operations, naming Abhay Gandhi as CEO of its North American business. Kal Sundaram, CEO of North American business, will move to India as CEO (India and emerging markets). Read: Sun Pharma introduces anti-cancer product in Europe “Effective August 2016, Abhay